The settlement is the latest in a string of big-money cases involving the sales practices of major pharmaceutical companies; four years ago, Pfizer paid $2.3 billion for improperly marketing several drugs. The recent case centers on the practices of Wyeth Pharmaceuticals, which Pfizer acquired…
Source:Pfizer Settles a Drug Marketing Case for $491 Million
Tuesday, July 30, 2013
Pfizer Settles a Drug Marketing Case for $491 Million
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment